C-Rad AB (publ) Total Assets
C-Rad AB (publ) total assets. Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) holds total assets worth Skr500.80 Million SEK (≈ $53.89 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of C-Rad AB (publ) for the company's overall valuation and market capitalisation.
Total Assets of C-Rad AB (publ) (2008–2025)
Total assets of C-Rad AB (publ) from 2008 to 2025. This chart illustrates how C-Rad AB (publ)'s total assets have evolved over time, based on quarterly financial data. See CRAD-B stock price and chart for real-time trading data and today's change.
C-Rad AB (publ) - Asset Composition Analysis
C-Rad AB (publ) Total Assets Breakdown (December 2025)
C-Rad AB (publ) total assets breakdown as of December 2025. C-Rad AB (publ)'s total assets of Skr500.80 Million consist of 87.5% current assets and 12.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 34.2% |
| Accounts Receivable | Skr157.70 Million | 31.5% |
| Inventory | Skr45.70 Million | 9.1% |
| Property, Plant & Equipment | Skr23.80 Million | 4.8% |
| Intangible Assets | Skr39.00 Million | 7.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how C-Rad AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore C-Rad AB (publ) (CRAD-B) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: C-Rad AB (publ)'s current assets represent 87.5% of total assets in 2025, an increase from 44.2% in 2008.
- Cash Position: Cash and equivalents constituted 34.2% of total assets in 2025, up from 33.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, unchanged from 7.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 31.5% of total assets.
C-Rad AB (publ) Competitors by Total Assets
Key competitors of C-Rad AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
C-Rad AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.09 | 2.89 | 3.90 |
| Quick Ratio | 2.77 | 2.54 | 3.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr296.20 Million | Skr288.15 Million | Skr164.50 Million |
C-Rad AB (publ) - Advanced Valuation Insights
This section examines the relationship between C-Rad AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.68 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | Skr500.80 Million |
| Market Capitalization | $82.28 Million USD |
Valuation Analysis
Below Book Valuation: The market values C-Rad AB (publ)'s assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: C-Rad AB (publ)'s assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for C-Rad AB (publ) (2008–2025)
The table below shows the annual total assets of C-Rad AB (publ) from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr500.80 Million ≈ $53.89 Million |
+2.34% |
| 2024-12-31 | Skr489.36 Million ≈ $52.66 Million |
+21.13% |
| 2023-12-31 | Skr404.00 Million ≈ $43.48 Million |
+19.11% |
| 2022-12-31 | Skr339.17 Million ≈ $36.50 Million |
+10.59% |
| 2021-12-31 | Skr306.71 Million ≈ $33.01 Million |
+13.38% |
| 2020-12-31 | Skr270.52 Million ≈ $29.11 Million |
+71.44% |
| 2019-12-31 | Skr157.79 Million ≈ $16.98 Million |
+7.62% |
| 2018-12-31 | Skr146.61 Million ≈ $15.78 Million |
+24.19% |
| 2017-12-31 | Skr118.06 Million ≈ $12.70 Million |
+15.63% |
| 2016-12-31 | Skr102.10 Million ≈ $10.99 Million |
+38.68% |
| 2015-12-31 | Skr73.63 Million ≈ $7.92 Million |
+1.32% |
| 2014-12-31 | Skr72.66 Million ≈ $7.82 Million |
+17.63% |
| 2013-12-31 | Skr61.77 Million ≈ $6.65 Million |
+62.03% |
| 2012-12-31 | Skr38.12 Million ≈ $4.10 Million |
-29.66% |
| 2011-12-31 | Skr54.20 Million ≈ $5.83 Million |
-20.08% |
| 2010-12-31 | Skr67.82 Million ≈ $7.30 Million |
+51.26% |
| 2009-12-31 | Skr44.84 Million ≈ $4.83 Million |
-7.33% |
| 2008-12-31 | Skr48.38 Million ≈ $5.21 Million |
-- |
About C-Rad AB (publ)
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more